PharmaIN
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11812 N Creek Pkwy N Ste 101, Bothell, W...Phone Number
(206) 568-1450Website
www.pharmain.comRevenue
<$5 MillionIndustry
About PharmaIN
PharmaIN Corporation is a clinical stage biopharmaceutical company specializing in the development of first- and best-in-class subcutaneous therapies through innovative peptide engineering. The company focuses on creating novel treatments for patients suffering from advanced liver cirrhosis and cancer, leveraging its expertise in target-specific biology and peptide drug design. PharmaIN aims to revolutionize the treatment landscape with self-injectable therapies that enhance patients' ability to manage their health independently. Currently, the company is advancing its lead product, PHIN-214, through clinical trials and is actively seeking strategic partnerships for further development.Explore more
PharmaIN Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to PharmaIN
Compare insights from companies similar to PharmaIN, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
PharmaIN Tech Stack
A closer look at the technologies used by PharmaIN
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PharmaIN
Sign Up For FreeTo access detailed company insights
PharmaIN Corporation is a clinical stage biopharmaceutical company specializing in the development of first- and best-in-class subcutaneous therapies through innovative peptide engineering. The company focuses on creating novel treatments for patients suffering from advanced liver cirrhosis and cancer, leveraging its expertise in target-specific bi... Read More
